UAB is recruiting postpartum women who are still lactating, for a study on the effects of the antiretroviral drug used to prevent HIV transmission.
UAB's David Freedman, M.D., a professor of infectious diseases and a leading expert on international medicine and emerging diseases, discusses the Zika virus, touching on who is at risk, how to prevent infection and the likelihood of an United States outbreak.
Two prominent faculty members from the UAB Department of Medicine have been elected to become members of the American Society for Clinical Investigation (ASCI).
A UAB study reconfirms that single-dose azithromycin remains an effective treatment for chlamydia, especially when drug adherence is an issue.
The UAB Undiagnosed Diseases Program, designed to help find answers for rare medical conditions, now has a clinic in Children’s of Alabama.
UAB researchers collaborated on a study showing a blood test for chlamydia might be valuable in screening infertile women for pregnancy outcomes.
In JAMA Viewpoint, Edward W. Hook III, M.D., says doctors and patients must be willing to talk about sex if we are to decrease the nation’s rate of sexually transmitted infections.
Professor Ravi Bhatia, M.D., is the next holder of the Martha Ann and David L. May Endowed Chair in Cancer Research, and Professor Edward W. Hook III, M.D., was chosen to be the inaugural holder of the Cobbs Endowed Professorship in Infectious Diseases.
HIV/AIDS is the leading cause of death worldwide for women ages 15-44 years, and UAB serves as a site for the latest study by the Microbicide Trials Network, which has previously studied this new approach with positive results in other female age groups.
Nicholas Van Wagoner, M.D., Ph.D. recently joined the Department of Medical Student Services as assistant dean for students.